fbpx
Arbor Vita Corporation Navigation
  • COVID-19 Testing
  • OncoE6™ Cervical Test
  • News
  • Products
  • About
  • Contact
  • Search
  • COVID-19 Testing
  • OncoE6™ Cervical Test
  • News
  • Products
  • About
  • Contact
  • Search

Category Archive

View Post

Global Health Resident to Lead Cervical Cancer Project Funded by a Grand Challenges Explorations Grant

In Press Release by Bryan Beacraft06/06/2016

Laura Musselwhite, an internal medicine resident in the Hubert-Yeargan Center’s Global Health Pathway, will be the principal investigator for a recently awarded Grand Challenges …

Read More
View Post

Brazilian Collaborators Launch OncoE6™ Cervical Test Study in the Amazon

In Press Release by arborvita_admin02/06/2015

Fremont, California [February 6, 2015] – Arbor Vita Corporation, a privately held company, announced today that its Brazilian collaborators have launched a study implementing …

Read More

The OncoE6™Cervical Test Presented at EUROGIN

In Press Release by arborvita_admin02/04/2015

Fremont, California [February 4, 2015] – Arbor Vita Corporation, a privately held company, is presenting its groundbreaking OncoE6TM Cervical Test, a new point-of-care proteomic-based …

Read More
View Post

The OncoE6™ Cervical Test Presented to the French Association for the Study of Papillomavirus and Polyomavirus Infections (AFIPP)

In Press Release by arborvita_admin10/22/2014

Fremont, California [October 22, 2014] – Arbor Vita Corporation, a privately held company, presented its groundbreaking OncoE6TM Cervical Test, a new point-of-care proteomic-based diagnostic, …

Read More

Arbor Vita Corporation Signs Distribution Agreement with AB ANALITICA

In Press Release by arborvita_admin09/03/2014

Fremont, California [September 3, 2014] — Arbor Vita Corporation, a privately held company, announced today that AB ANALITICA will distribute the OncoE6TM Cervical Test …

Read More
  • Page 1 of 2
  • 1
  • 2
  • →

For Professionals

  • Feasibility Study of a Human Papillomavirus E6 Oncoprotein Test for Diagnosis of Cervical Precancer and Cancer
  • Clinical Test for HPV Induced Cancer in Low Resource Settings Via Direct Detection of Elevated HPV E6 Oncoprotein
  • Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china
  • Formation of well-defined soluble aggregates upon fusion to MBP is a generic property of E6 proteins from various human papillomavirus species
  • The Human Papillomavirus E6 Oncogene Dysregulates the Cell Cycle and Contributes to Cervical Carcinogenesis through Two Independent Activities
  • Association of Elevated E6 Oncoprotein With Grade of Cervical Neoplasia Using PDZ InteractionYMediated Precipitation of E6
  • An Evaluation of Novel, Lower-Cost Molecular Screening Tests for Human Papillomavirus in Rural China
  • Lower cost strategies for triage of human papillomavirus DNA-positive women

About Arbor Vita

  • Support
  • Careers
  • Terms and Conditions

Location

Arbor Vita Corporation
48371 Fremont Blvd, Suite 101
Fremont, CA 94538
USA

Contact Us

Phone: 650-713-7932
Fax: +1 (510) 573-4758
Email: info@arborvita.com

Social Media

Twitter
  • Twitter
  • LinkedIn